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TGFbactivated kinase 1 (TAK1), a member of the MAPKKK
family, controls diverse functions ranging from innate and
adaptive immune system activation to vascular develop-
ment and apoptosis. To analyse the in vivo function of
TAK1 in cartilage, we generated mice with a conditional
deletion of Tak1 driven by the collagen 2 promoter.
Tak1
col2 mice displayed severe chondrodysplasia with
runting, impaired formation of secondary centres of ossi-
ﬁcation, and joint abnormalities including elbow disloca-
tion and tarsal fusion. This phenotype resembled that of
bone morphogenetic protein receptor (BMPR)1 and Gdf5-
deﬁcient mice. BMPR signalling was markedly impaired in
TAK1-deﬁcient chondrocytes as evidenced by reduced ex-
pression of known BMP target genes as well as reduced
phosphorylation of Smad1/5/8 and p38/Jnk/Erk MAP
kinases. TAK1 mediates Smad1 phosphorylation at C-term-
inal serine residues. These ﬁndings provide the ﬁrst in
vivo evidence in a mammalian system that TAK1 is re-
quired for BMP signalling and functions as an upstream
activating kinase for Smad1/5/8 in addition to its known
role in regulating MAP kinase pathways. Our experiments
reveal an essential role for TAK1 in the morphogenesis,
growth, and maintenance of cartilage.
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Introduction
During endochondral ossiﬁcation, mesenchymal stem cells
undergo a highly organized differentiation program during
which they condense and differentiate into chondrocytes,
forming the template for bone formation (Kronenberg,
2003; Yoon and Lyons, 2004). Bone morphogenic proteins
(BMPs) were originally isolated as proteins that promote
ectopic cartilage and bone formation (Wozney et al, 1988).
Further studies have conﬁrmed the role of BMPs in cell
proliferation, differentiation, and apoptosis during cartilage
and bone formation and revealed additional functions in
other developmental processes (Yoon and Lyons, 2004). For
example, BMP-2 and BMP-4 are essential for the induction of
ventral mesoderm formation during early mouse develop-
ment (Winnier et al, 1995). BMP family members transduce
signals through heteromeric complexes of type II and type I
transmembrane serine/threoine kinase receptors. Type II
receptor ligation initiates the recruitment of type I receptors
to form heteromeric receptor complexes that are then trans-
phosphorylated. The type I receptors in turn initiate Smad
signalling by phosphorylating the receptor-regulated Smads,
R-Smad1/5/8. Once phosphorylated, R-Smads associate with
Smad4 and accumulate in the nucleus to regulate gene
expression (Massague, 1998). In addition to the Smad-depen-
dent pathway, BMPs can also activate TGFb activated
kinase 1 (TAK1) leading to MKK3/6-mediated p38 MAP
kinase activation. However, the mechanism by which TAK1
regulates BMP signalling in chondrocytes is largely unknown
(Derynck and Zhang, 2003).
TAK1, a member of the MAPKKK family, was originally
identiﬁed as a key regulator of MAPK kinase activation in
TGFb and BMP signalling pathways (Yamaguchi et al, 1995).
In Xenopus development, TAK1 mediates mesoderm induc-
tion and patterning downstream of BMP ligands (Shibuya
et al, 1998). Mutations in the mouse Tak1 gene causes defects
in the developing intraembryoinc vasculature and yolk sac,
phenotypes similar to those caused by loss of function
mutations in SMAD5 (Chang et al, 1999; Shim et al, 2005;
Jadrich et al, 2006), suggesting that TAK1 may be important
for Smad activation downstream of BMP stimulation.
However, no biochemical or in vivo functional data currently
exist to support this hypothesis.
Because of the early lethality of mice with a germline
deletion of Tak1, cellular studies in these mice were limited
to mouse embryonic ﬁbroblasts (MEFs). TAK1-deﬁcient
MEFs displayed normal activation of canonical Smads after
TGFb stimulation, despite displaying a block in NF-kB and
JNK activation by microbial products in the innate immune
system (Shim et al, 2005). TAK1 also has critical functions in
the regulation of adaptive immunity where it is required for
antigen receptor signalling in both Tcells and B cells through
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2028its regulation of NF-kB and JNK activation (Sato et al, 2005,
2006; Liu et al, 2006; Wan et al, 2006). In addition to its role
in the immune system, TAK1 functions as a key regulator of
vascular development and keratinocyte proliferation, differ-
entiation, and apoptosis (Omori et al, 2006; Sayama et al,
2006) and mediates survival of hematopoietic cells and
hepatocytes through its regulation of NF-kB and JNK activa-
tion (Tang et al, 2008).
Given earlier studies suggesting a role for TAK1 in signal-
ling downstream of both the BMP and TGFb signalling path-
ways and the importance of these pathways for chondrocyte
biology, we decided to generate mice with cartilage-speciﬁc
deletion of the Tak1 gene to address the physiological roles of
mammalian TAK1 in cartilage. Deletion of Tak1 in chondro-
cytes resulted in a dramatic runting phenotype with chon-
drodysplasia and joint abnormalities similar to that seen in
mice deﬁcient in BMP signalling. Biochemical analysis of
TAK1-deﬁcient chondrocytes conﬁrmed a defect in BMP
signalling that unexpectedly resulted in impaired Smad1/5/
8 activation in addition to defective p38/Jnk/Erk MAP kinase
signalling. We provide the ﬁrst evidence that TAK1 is required
for the normal development and preservation of cartilage.
Results
Expression of TAK1 in cartilage
As the expression pattern for TAK1 in cartilage is unknown,
we stained for TAK1 using immunohistochemistry (IHC) on
coronal tibial sections from a postnatal day 20 (p20) mouse
(Figure 1). TAK1 staining was largely restricted to prehyper-
trophic and hypertrophic chondrocytes. Hypertrophic chon-
drocytes from both the terminal growth plate and the area
surrounding the secondary centre of ossiﬁcation showed
positive staining. Additionally, TAK1 expression in E16.5
embryos was examined. TAK1 is widely expressed in multiple
embryonic cartilage tissues, including the chondroepiphyses
of the long bones, the laryngeal and tracheal cartilage, and
the developing frontal bone (Supplementary Figure S1).
Abnormal cartilage development in TAK1-deﬁcient mice
To determine the role of TAK1 in cartilage development, we
generated mice lacking Tak1 in cartilage by intercrossing a
Tak1 ﬂoxed-allele strain of mice with a type II collagen-cre
deleter strain (Ovchinnikov et al, 2000). IHC for TAK1
expression conﬁrmed deletion speciﬁcally in chondrocytes,
with staining absent in both the terminal growth plate and
the hypertrophic chondrocytes surrounding the secondary
centre of ossiﬁcation (Figure 1). Animals homozygous for
the ﬂoxed allele expressing the cre transgene (hereafter
referred to as Tak1
col2 mice) displayed severe postnatal
growth retardation culminating in death by 2–3 weeks of
age (Figure 2A). As shown in Alizarin red S/Alcian blue
stained skeletal preps of p20 mice, Tak1
col2 mice showed
proportional shortening of the long bones of the limbs, a
‘doming’ of the cranium, malocclusion, and kyphosis of the
thoracic spine (Figure 2A). Tak1
col2 postnatal day 0 (p0)
offspring showed a modest reduction in the length of long
bones and disorganization of proliferating chondrocyte col-
umns in the growth plate (Supplementary Figure S2A and B).
Animals heterozygous for the ﬂoxed allele expressing the cre
transgene showed no appreciable phenotype at any age (data
not shown). Histologic analysis of coronal sections of
Tak1
col2 tibias conﬁrmed a marked reduction in overall size
(Figure 2B). Additionally, the formation of secondary ossiﬁ-
cation centres was delayed, with Tak1
col2 mice showing only
minimal vascular invasion and calciﬁcation within the sec-
ondary centre of ossiﬁcation. Notably, Tak1
col2 chondrocytes
surrounding the secondary ossiﬁcation centre progressed
normally through the hypertrophic stage of differentiation
(Figure 2B, arrow).
To determine whether the runting observed in Tak1
col2
mice is the result of a delay in endochondral ossiﬁcation of
long bones, we performed in situ hybridization for osteopon-
tin on femurs from E16.5 embryos to highlight the ossiﬁed
portion of the bone (Supplementary Figure S2C). As Tak1
col2
embryos displayed a similar extent of ossiﬁcation, it is
unlikely that the runting phenotype observed postnatally is
the result of defects in the early stages of endochondral
ossiﬁcation. The long bones of E18.5 embryos were similarly
of comparable length to wild-type controls (data not shown).
Finally, in situ hybridization of Collagen Xa (ColX) was
performed to determine the effects of TAK1 deletion on
chondrocyte maturation (Figure 2C). Although p20 mice
displayed a moderate reduction in the size of the prehyper-
trophic/hypertrophic zone of ColX-positive chondrocytes,
E16.5 and E18.5 embryos were found to display normal
H
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Figure 1 Expression of TAK1 in the proximal tibia.
(A) Immunohistochemistry for TAK1 showing expression in a
coronal section of the proximal tibias of Tak1
ﬂ/ﬂ and Tak1
col2
mice. Secondary centres of ossiﬁcation are indicated with arrows,
hypertrophic chondrocytes in the terminal growth plate are indi-
cated with an ‘H’. (B) High power of the indicated areas of
(A), showing TAK1 expression in prehypertrophic and hypertrophic
chondrocytes.
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that the runting phenotype observed in Tak1
col2 mice has an
onset sometime between E18.5 and birth.
The overall reduction in the size of the Tak1
col2
chondroepiphysis could be due to increased chondrocyte
apoptosis or decreased chondrocyte proliferation. To deter-
mine the relative contributions of each, Tak1
col2 chondroepi-
physes were stained for proliferating cell nuclear antigen
(PCNA) as an index of cell proliferation and by terminal
deoxynucleotidyl transferase dUTP nick end labelling
(TUNEL) as a marker for apoptotic cells (Figure 2D).
Tak1
col2 chondroepiphyses displayed both a decrease in
chondrocyte proliferation in the prehypertrophic/proliferat-
ing zone of the growth plate and an increase in the apoptosis
of terminal hypertrophic chondrocytes, indicating that both
mechanisms contribute to the decrease in the size of the
chondroepiphysis.
Radiographs revealed dislocation of the elbow and a
corresponding lateral deviation of the forearm in Tak1
col2
mice (Figure 2E, upper panels). The penetrance of this
phenotype was B80% by two weeks of age. Alizarin red/
alcian blue stained skeletal preparations of the elbow showed
a similar disruption of the elbow architecture with the
formation of ectopic calciﬁcations in the joint space
(Figure 2E, lower panels). Tissue sections taken parallel to
the long axis of the forelimb showed that this phenotype
corresponds with an overgrowth of the articular cartilage on
the distal humerus facing the radius (Figure 2F, upper
panels). The proximal end of the radius has expanded
extensively around the protruding articular cartilage of the
humerus to the point of displacing the normal articulation
between the ulna and the distal humerus. To determine
whether the elbow phenotype observed postnatally repre-
sents a developmental defect in joint formation, we examined
the elbow joint of E14.5 embryos (Figure 2F, lower panels).
The distal humerus and the proximal radius were present as a
single continuous skeletal element in Tak1
col2 embryos,
whereas control embryos showed a clear cavitation of the
joint and a separation of the two skeletal elements. Cavitation
of the joint between the humerus and the ulna occurred
normally (data not shown). Considering that histologic ana-
lysis of the p20 elbow joint shows the presence of a joint
space between the distal humerus and proximal radius, this
indicates that Tak1
col2 mice display a delay in cavitation of
the humero-radial joint space.
In addition, as shown in the high-power views of skeletal
preparations (Figure 2G), the phalanges of the hindlimbs
show a marked medial deviation and the tarsals show a
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Figure 2 Abnormal cartilage development of TAK1-deﬁcient mice. (A) Skeletal preparations of 3 week old Tak1
ﬂ/ﬂ and Tak1
col2 mice (upper
panels). X-ray of the skull of 3 week old Tak1
ﬂ/ﬂ and Tak1
col2 mice, showing doming of the skull and malocclusion in Tak1
col2 mice (lower
panels). (B) Histological analysis of the proximal tibia of Tak1
ﬂ/ﬂ and Tak1
col2 mice. Haematoxylin and eosin-stained sections through the
proximal tibia of 3 week old Tak1
ﬂ/ﬂ and Tak1
col2 mice. The proximal tibia of Tak1
col2 mice is smaller and shows impaired formation of
secondary ossiﬁcation centres (indicated with an arrow). (C) In situ hybridization for Collagen X/(ColX) in the proximal humerus of E16.5 and
E18.5 Tak1
ﬂ/ﬂ and Tak1
col2 mice, demonstrating similar extent of chondrocyte hypertrophy. (D) PCNA (top panel) and TUNEL (bottom panel)
staining on the chondroepiphyses of p0 Tak1
ﬂ/ﬂ and Tak1
col2 mice, demonstrating a decrease in PCNA-positive cells and an increase in TUNEL-
positive terminal hypertrophic chondrocytes. (E) X-rays and alizarin red/alcian blue stained skeletal preparations of the elbows of 3 week old
Tak1
ﬂ/ﬂ and Tak1
col2 mice, showing dislocation in Tak1
col2 mice. (F) Histological analysis of the elbow of Tak1
ﬂ/ﬂ and Tak1
col2 mice.
Haematoxylin and eosin-stained sections through elbows of p20 and E14.5 Tak1
ﬂ/ﬂ and Tak1
col2 mice. Tak1
col2 mice show an overgrowth of the
cartilage on the distal humerus and a widening of the proximal radius. The humerus (H), radius (R), and ulna (U) are labelled. (G) High-power
view of the ankle of alizarin red/alcian blue stained skeletal preparations of 3 week old Tak1
ﬂ/ﬂ and Tak1
col2 mice, showing fusion of the tarsal
bones and medial dislocation of the phalanges. C, intermediate cuneiform; LC, lateral cuneiform; CU, cuboid; NC, navicular; CA, calcaneus;
TA, talus.
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cuneiform, intermediate cuneiform, navicular, and calcaneus
all forming a continuous skeletal element. Although the
tarsals of the littermate control mouse show complete ossiﬁ-
cation by 20 days of age, the fused tarsal element of Tak1
col2
mice shows incomplete ossiﬁcation with a layer of Alcian
blue positive cartilage surrounding the ossiﬁed centre. In
contrast, the hip, shoulder, and temperomandibular joints
showed no signs of developmental abnormalities (data not
shown). Thus, Tak1
col2 mice show both impaired growth of
skeletal elements and defects in the elbow and tarsal joints. In
this respect, they resemble a mixture of the tarsal and elbow
abnormalities observed in GDF5-deﬁcient mice and the long
bone abnormalities present in mice lacking BMP 2/4/7
(Storm et al, 1994).
Reduced levels of BMP signalling in TAK1-deﬁcient mice
Overall phenotypic similarities between Tak1
col2 mice and
mice with speciﬁc deletions of multiple BMP receptor sub-
units in chondrocytes suggested a role for TAK1 in BMP
signalling pathways (Yoon et al, 2005). To address this
possibility directly, we performed immunostaining analysis
for the phosphorylation of Smad 1/5/8 (BMP-responsive
Smads) in the proximal tibia of Tak1
ﬂ/ﬂ and Tak1
col2 mice.
Phosphorylation levels of Smad1/5/8 were signiﬁcantly
reduced in the hypertrophic chondrocytes of Tak1
col2 mice
(Figure 3A). Similarly, immunoblotting analysis of primary
chondrocytes showed decreased basal levels of phosphory-
lated Smad 1/5/8 in TAK1-deﬁcent chondrocytes derived
from p0 Tak1
col2 mice, as compared with littermate control
chondrocytes (Figure 3B). However, Tak1 deletion did not
affect the ex vivo basal phosphorylation levels of Smad2, and
levels of Smad1 and Bmpr1A protein in TAK1-deﬁcient
chondrocytes were comparable to wt chondrocytes
(Figure 3B). Hence, Tak1 deletion results in reduced levels
of activated Smad1/5/8 in vivo implying that TAK1 may
regulate BMP-responsive Smad activation (Smad1/5/8), but
not TGFb-responsive Smad activation (Smad2). In addition,
TAK1 appears to regulate Smad phosphorylation rather than
altering expression of BMP signalling components. P38 is also
known to be phosphorylated downstream of BMP stimula-
tion; however, we were unable to determine phospho-p38
levels in cartilage in vivo by IHC, despite multiple attempts.
As BMP signalling was reduced in both in vivo and ex vivo
measurements of phosphorylated signalling intermediates in
Tak1
col2 mice, we examined expression levels of known BMP
target genes in vivo. Indian hedgehog (IHH) is a key regulator
of bone formation that coordinates both chondrocyte
proliferation/differentiation and osteoblast differentiation
(Kronenberg, 2003). Mice in which chondrocytes are geneti-
cally unable to respond to BMPs show decreased expression
of IHH in prehypertrophic chondrocytes, and this is proposed
P-Smad1/5/8
Tak1ﬂ/ﬂ Tak1col2
Tak1col2 Tak1col2 Tak1ﬂ/ﬂ Tak1ﬂ/ﬂ
H
ColX
H
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TAK1
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Smad1
Tak1: ﬂ/ﬂ col2 col2
Bmpr1A
P-Smad2
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1° cultured chondrocytes 
P-SMAD1/5/8
ID1
H
IHH
Patched
H
Figure 3 Reduced BMP signalling in TAK1-deﬁcient mice. (A) Immunohistochemistry for phosphorylation of BMP-responsive Smad proteins.
Coronal sections of the proximal tibia of P0 Tak1
ﬂ/ﬂ and Tak1
col2 pups were stained with anti-phospho-Smad1/5/8 antibody. Hypertrophic
chondrocytes in the terminal growth plate are indicated with an ‘H’. (B) Primary chondrocytes were isolated from cartilage tissues of p0 Tak1
ﬂ/ﬂ
and Tak1
col2 mice, cultured for 3 days, and immunoblotted with the indicated antibodies. (C) In situ hybridization for IHH, Patched, ID1, and
Collagen Xa (ColX). Coronal sections of the proximal tibia of 3 week old Tak1
ﬂ/ﬂ and Tak1
col2 mice were probed for the expression of the
indicated mRNAs. The hypertrophic region of the growth plate is shown.
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these mice (Grimsrud et al, 2001; Yoon et al, 2006). We tested
whether a similar reduction in IHH might contribute to the
runting seen in Tak1
col2 mice (Figure 3C, left panels). In situ
hybridization of the proximal tibia with IHH probes showed a
moderate decrease of IHH transcript levels in the hypertropic
chondrocytes of Tak1
col2 mice. To show that this reduction in
IHH transcript levels resulted in a functional decrease in IHH
signalling in vivo, we also performed in situ hybridization to
quantify levels of the IHH target gene, patched (Figure 3C, left
panels). Patched expression was reduced in both prehyper-
trophic chondrocytes and in the bone collar. The reduction in
patched expression even outside of cartilage strongly sug-
gests that TAK1 functions upstream of IHH expression in
hypertrophic chondrocytes and not in signal transduction
downstream of IHH.
To conﬁrm a functional defect in BMP signalling in vivo,
we performed in situ hybridization to measure the transcript
levels of Id1, a known BMP target gene in multiple systems
(Miyazono and Miyazawa, 2002). ID1 expression was almost
completely ablated in the hypertrophic chondrocytes of
Tak1
col2 mice, whereas expression of type X collagen
(ColX), the major extracelluar matrix marker for hypertrophic
chondrocytes, was little affected by Tak1 deletion, showing
only a modest reduction in the overall size of the hyper-
trophic zone (Figure 3C, right panels). These ﬁndings suggest
that TAK1 is indispensable for the in vivo response to BMPs in
the terminal growth plate.
Impaired BMP signalling in TAK1-deﬁcient
chondrocytes
BMP signalling through Smad1/5/8 is required for the induc-
tion of several canonical BMP target genes, including Id1,
Msx1, and Noggin (Kameda et al, 1999; Miyazono and
Miyazawa, 2002; Wan and Cao, 2005; Binato et al, 2006).
We analysed the induction of these BMP target genes in
primary TAK1-deﬁcient chondrocytes by using a quantitative
RT–PCR assay (Figure 4A). After activation by BMP2/7, wt
but not TAK1-deﬁcient chondrocytes showed an appreciable
induction in levels of Id1, Msx1, and Noggin transcripts
consistent with a role for TAK1 in mediating BMP-induced
gene expression in chondrocytes.
To facilitate further biochemical analysis, we immortalized
primary chondrocytes derived from Tak1
ﬂ/ﬂ and Tak1
col2
newborn offspring by stably transfecting them with the
SV40 large T antigen (Kobayashi et al, 2005; Shim et al,
2005). Immunoblotting for TAK1 conﬁrmed a signiﬁcant
reduction in TAK1 expression in Tak1
col2 relative to Tak1
ﬂ/ﬂ
chondrocytes (Supplementary Figure S3A). As deletion of
Tak1 by col2-cre is not 100% efﬁcient and chondrocytes
were maintained as bulk cultures rather than colonies to
avoid clonal artifacts, residual TAK1 expression is present in
Tak1
col2 chondrocyte cultures. We tested the requirement for
TAK1 in BMP or TGFb signalling by measuring BMP/TGFb-
dependent promoter activation. Cells were transfected with
BMP or TGFb-responsive luciferase reporters and stimulated
with BMP2/7 or TGFb (Figure 4B and C). Tak1
ﬂ/ﬂ chondro-
cytes showed approximately two-fold induction in luciferase
reporter activity in response to BMP2/7, whereas Tak1
col2
chondrocytes showed no response. Similarly, overexpression
of a catalytically inactive TAK1 mutant (DN/K63W; hereafter
CI) blocked gene induction in wt chondrocytes in response to
BMP2/7 (Figure 4B, right panel). TGFb-induced luciferase
reporter activity was not affected by Tak1 deletion, suggest-
ing that, in chondrocytes, TAK1 is important for BMP but not
TGFb signalling (Figure 4C).
Reduced activation of Smad and MAP kinase pathways
by BMPs in TAK1-deﬁcient chondrocytes
It has been reported that BMP signalling is mediated by two
distinct pathways: the canonical Smad pathway and the
TAK1-p38 MAP kinase pathway (Derynck and Zhang,
2003). We examined the activation of these two arms of
BMP signalling in TAK1-deﬁcient chondrocytes by immuno-
blotting with antibodies speciﬁc for phospho-Smad1/5/8 and
phospho-p38 (Figure 4D). In the absence of TAK1, Smad1/5/
8 phosphorylation was moderately decreased, and a small,
but reproducible decrease in the electrophoretic mobility of
phosphorylated Smad proteins was detected. However, Tak1
deletion did not affect total Smad1 protein levels, implying
that TAK1 regulates Smad phosphorylation rather than alter-
ing expression of Smad1/5/8 (Supplementary Figure S3C).
Tak1
col2 chondrocytes exhibited impaired activation of p38,
Erk1/2, and Jnk1/2 MAP kinases in response to BMP2/7,
implying that TAK1 may function as a key regulator of BMP-
mediated MAP kinase activation (Figure 4D and E).
Immunoﬂuorescence staining for phospho-Smad1/5/8 after
BMP2/7 stimulation showed that phosphorylated Smad1/5/8
was still able to translocate to the nucleus in the absence of
TAK1, though the total levels of phosphorylated Smad1/5/8
were decreased (Supplementary Figure S3D).
Next, we examined TGFb-induced activation of the cano-
nical Smad and MAP kinase pathway in TAK1-deﬁcient
chondrocytes by immunoblotting for phospho-Smad2 and
phospho-p38 (Figure 4F). Tak1
col2 cells exhibited a signiﬁcant
decrease in TGFb-induced p38 phosphorylation, whereas
Smad2 phosphorylation occurred normally. This is consistent
with earlier studies showing a requirement for TAK1 in the
MAP kinase but not the canonical Smad pathway down-
stream of TGFb (Yamaguchi et al, 1995; Shim et al, 2005).
Taken together, these results suggest that TAK1 is important
for the activation of both the canonical Smad (Smad1/5/8)
and MAP kinase pathways downstream of BMP2/7, whereas
downstream of TGFb, TAK1 is important for the activation of
p38 MAP kinase but not Smad2.
TAK1 mediates phosphorylation of Smad proteins
The decreased levels of Smad1/5/8 phosphorylation in
Tak1
col2 chondrocytes might be explained by a requirement
for TAK1 in the association of the bone morphogenetic
protein receptor (BMPR) complex with phosphorylated
Smad1/5/8. However, immunoprecipitation analysis showed
that in TAK1-deﬁcient chondrocytes, the interaction between
BMPR1A and phosphorylated Smad1/5/8 occurs normally,
5–15min postinduction with BMP2/7 (Supplementary Figure
S3E). Thus, Tak1 deletion does not affect the stability of the
interaction between the BMPR complex and phosphorylated
Smad proteins.
To test whether TAK1 interacts with Smad proteins,
HEK293 cells were transfected with Flag-tagged Smad pro-
teins along with HA-tagged TAK1 (Supplementary Figure
S4A). When overexpressed, Smad1, 2, 4, 5, and 8 all interact
with TAK1, although the Smad4 association was weak. To test
for direct interactions between TAK1 and BMP-responsive
Role of TAK1 in BMP signalling in chondrocytes
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with Flag-tagged Smad proteins and in vitro translated,
35S-labelled TAK1 (Figure 5A, upper panel). Under these
conditions, TAK1 interacted directly with Smad1, 5, and 8
and this likely occurs through the conserved MH2 domain of
Smad proteins as shown in an earlier study (Hoffmann et al,
2005). The TAK1 domain located between aa 200 and 300 is
required for binding to Smad1 (Supplementary Figure S4B).
This was conﬁrmed by a GST pull down assay with GST-
Smad1 and in vitro translated,
35S-labelled TAK1 (Figure 5A,
lower panel). Importantly, analysis of endogenous TAK1 and
Smad1 showed an association 5–15min after stimulation
with BMP2/7, kinetics similar to the rate of Smad1/5/8
phosphorylation indicating that TAK1 interacts with BMP-
responsive Smad proteins in chondrocytes in an inducible
manner (Figure 5B). In contrast, catalytically inactive TAK1
did not associate with Smad 1/5/8 although it did interact
with TAB1, a known TAK1-binding protein (Supplementary
Figure S4C and D) (Komatsu et al, 2002; Hoffmann et al,
2005). These results indicate that the kinase activity of TAK1
is necessary for its interactions with Smad proteins.
As TAK1 interacts directly with Smad proteins after BMP
stimulation, we tested whether TAK1 is able to induce
phosphorylation of Smad proteins. In vitro kinase assays
using HA-TAK1 immunoprecipitates from HEK293 cells trans-
fected with HA-tagged constitutively active TAK1 (DN) or
catalytically inactive TAK1 (CI; DN/K63W) (Yamaguchi et al,
1995) were incubated with recombinant GST, GST-Smad1,
-Smad2, or -Mkk6 (Figure 5C). As expected, GST-Mkk6,
a known TAK1 substrate, was phosphorylated by HA-TAK1
(DN), but not HA-TAK1 (CI). Notably, GST-Smad1 and
-Smad2 were also both phosphorylated by HA-TAK1 (DN)
but not HA-TAK1 (CI), indicating that TAK1 can phosphor-
ylate Smad proteins. Given that TAK1 can bind and phos-
None
BMP2/7
R
e
l
a
t
i
v
e
t
r
a
n
s
c
r
i
p
t
 
l
e
v
e
l
ID1 Msx1  Noggin
Tak1: ﬂ/ﬂ col2
Tak1: ﬂ/ﬂ col2
ﬂ/ﬂ col2 ﬂ/ﬂ col2
ﬂ/ﬂ col2
None BMP2/7
T
l
x
2
 
l
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y
T
l
x
2
 
l
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y None BMP2/7
Vec CI 
3
T
P
 
l
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y None TGFβ
P-Smad
1/5/8
GAPDH
BMP: 15 30 90 01 5 3 0 9 0 0 15 30 60 01 5 3 0 6 0 0 (min)  (min) 
15 30 90 01 5 3 0 9 0 0 (min) 
Tak1ﬂ/ﬂ  Tak1col2 Tak1ﬂ/ﬂ  Tak1col2
Tak1ﬂ/ﬂ  Tak1col2
P-p38
IB
P-Smad2
GAPDH
TGFβ:
P-p38
IB
P-Erk1/2
P-Jnk1/2
Hsp90
 BMP:
IB
35 2
1.8
1.6
1.4
1.2
0.8
0.6
0.4
0.2
1
0
30
25
20
15
10
5
0
200
180
160
140
120
100
80
60
40
20
0
3000
2500
2000
1500
1000
500
700
600
500
400
300
200
100
0 0
3000
2500
2000
1500
1000
500
0
Figure 4 Reduced BMP signalling in TAK1-deﬁcient chondrocytes. (A) Real time-PCR analysis for BMP-responsive gene induction in primary
chondrocytes. Tak1
ﬂ/ﬂ and Tak1
col2 chondrocytes were treated with or without BMP2/7 (100ng/ml) for 6h and total RNA was extracted for
RT–PCR analysis. (B, C) Immortalized chondrocytes were transfected with either Tlx2-lux (upper panel) or 3TP-luc (lower panel) and Renilla
luciferase vectors. Cells were serum starved for 12h before treatment with BMP2/7 (upper panel) or TGFb (lower panel), and then analysed for
luciferase activity. Results are expressed as relative luciferase activity normalized by Renilla control. (D, E) Immortalized Tak1
ﬂ/ﬂ and Tak1
col2
chondrocytes were serum starved for 12h before BMP2/7 (100ng/ml) stimulation for the indicated times, and then immunoblotted with
antibodies speciﬁc to phospho-Smad1/5/8 (D), phospho-Erk1/2, or phospho-Jnk1/2 (E). Immunoblotting analysis with antibodies speciﬁc to
GAPDH (D) or Hsp90 (E) was performed as a control. (F) Immortalized Tak1
ﬂ/ﬂ and Tak1
col2 chondrocytes were serum starved for 12h before
TGFb (2ng/ml) stimulation for the indicated times, and then immunoblotted with antibodies speciﬁc to phospho-Smad2 and phospho-p38.
Immunoblotting analysis with anti-GAPDH antibody was performed as a control.
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Smad phosphorylation in both BMP and TGFb signalling
pathways. To test this hypothesis, we analysed TAK1-
mediated phosphorylation of Smad1 and 2 after BMP and
TGFb stimulation using in vitro kinase assays (Figure 5D).
Surprisingly, little GST-Smad2 phosphorylation was detected
in response to TGFb, whereas GST-Smad1 was strongly
phosphorylated with peak activity 15min postinduction by
BMP2/7. However, GST-Mkk6 was equivalently phosphory-
lated after stimulation with either TGFb or BMP2/7, indicat-
ing that TAK1 is similarly activated downstream of TGFb and
BMP2/7 signalling (Figure 5E) (Yamaguchi et al, 1995). Thus,
differences in the intrinsic activation status of TAK1 are
unlikely to account for the selective phorphorylation of
Smad1 and not Smad2 by endogenous TAK1. This may
explain why the Tak1
col2 mice bear a much greater resem-
blance to mice with defects in BMP but not TGFb signalling in
chondrocytes (Yi et al, 2000; Yoon et al, 2005).
Identiﬁcation of TAK1 phosphorylation sites in Smad1
Coomassie blue staining showed a slight mobility shift of
the isolated Smad1 protein when co-expressed with TAK1,
implying that TAK1 induces posttranslational modiﬁcation of
Smad1 (Figure 6A). To identify the TAK1-mediated phosphor-
ylation sites in Smad1, we performed mass spectrometry
analysis. HEK293 cells were transfected with Flag-Smad1
together with either vector control or constitutively active
TAK1 (DN), and immunoprecipitated using Flag-conjugated
agarose. As Smad1 interacts with TAK1 through its MH2
domain, phosphopeptide analysis initially focused on this
region (Figure 6A, lower panel). Mass spectrometry analysis
revealed that, when co-expressed with TAK1, Smad1 is
phosphorylated at C-terminal serines (S463 and S465), the
same phosphorylation sites targeted by the BMP type I
receptor kinase (Tables I and II) (Hoodless et al, 1996;
Macias-Silva et al, 1996; Abdollah et al, 1997; Kretzschmar
et al, 1997b). This is consistent with the immunoblotting
analysis with anti-phospho-Smad1/5/8 (S463/S465, S426/
S428) showing that Flag-Smad1 is phosphorylated at C-term-
inal serines in the presence of HA-TAK1 (DN) (Figure 6B).
BMPR1 was not detectable in co-immunoprecipitations
with HA-TAK1 (DN), making it unlikely that the S463/S465
phosphorylation observed was mediated by BMPR1 that
co-puriﬁed with HA-TAK1 (Supplementary Figure S4E).
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Figure 5 TAK1 is an upstream kinase of Smad proteins in BMP signalling. (A) Direct interaction of TAK1 with BMP-responsive Smad proteins.
HEK293 cells were transfected with Flag-Smad1, 5, and 8, and lysed and immunoprecipitated with anti-Flag-conjugated beads. The interactions
were tested by Flag pull down assays with Flag-Smad proteins and in vitro translated,
35S-labelled TAK1 (upper panel). Alternatively, GST pull
down analysis was performed using either GST or GST-Smad1 and in vitro translated,
35S-labelled TAK1 (lower panel). (B) Endogenous
interaction of TAK1 with BMP-responsive Smad proteins. Immortalized chondrocytes were serum starved before BMP2/7 (100ng/ml)
stimulation for the indicated times, and then cells were lysed, immunoprecipitated with either Rabbit IgG or anti-TAK1 antibody and protein
A agarose, and immunoblotted with the indicated antibodies. (C) TAK1-induced phosphorylation of Smad proteins. HEK293 cells were
transfected with either vector control, constitutively active HA-TAK1 (DN), or catalytically inactive HA-TAK1 (CI) and immunoprecipitated with
anti-HA antibody and protein G agarose. The immunoprecipitates were mixed with GST, GST-Smad1, Smad2, or Mkk6, and TAK1 kinase
activity was analysed by in vitro kinase assay. (D, E) TAK1 activates BMP-responsive Smad1 more efﬁciently than TGFb-responsive Smad2.
Immortalized wt chondrocytes were serum starved for 12h before treatment with BMP2/7 (100ng/ml) or TGFb (2ng/ml) for the indicated time
and then immunoprecipitated with anti-TAK1 antibody. The immunoprecipitates were mixed with GST-Smad1 (BMP2/7), GST-Smad2 (TGFb)
(D), or GST-Mkk6 (E). TAK1 kinase activity was analysed by in vitro kinase assay.
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weaker than phosphorylation by constitutively active
BMPR1B (Q203D), implying that BMPR1B is able to phos-
phorylate Smad1 at C-terminal serines more efﬁciently than
TAK1 (Figure 6B) (Hoffmann et al, 2005). To test the ability of
TAK1 to induce Smad1 phosphorylation at C-terminal serines,
we generated recombinant GST-Smad1 containing the SSVS
to AAVA mutation, which is a poor substrate for the BMP type
I receptor kinase (Kretzschmar et al, 1997b). Mutation of the
S463/S465 site to AAVA led to a moderate decrease in TAK1
(DN)-induced phosphorylation, although it signiﬁcantly de-
creased BMPR1B (Q203D)-induced phosphorylation (Figure
6C and D). This is consistent with immunoblotting analysis
with anti-phospho-Smad1/5/8 (S463/S465, S426/S428)
showing that the phosphorylation level of Smad1 at S463/
S465 was moderately decreased in TAK1-deﬁcient chondro-
cytes in response to BMP2/7 (Figure 4D). Similarly, the AAVA
mutated Smad1 only showed a partial reduction in the level
of phosphorylation by the endogenous TAK1 complex im-
munoprecipitated from the wt chondrocyte line after BMP
stimulation (Figure 6D). Thus, these results strongly suggest
that TAK1 may phosphorylate Smad1 at sites in addition to
S463/S465.
Requirement of TAK1 kinase activity in BMP signalling
To test the absolute requirement for TAK1 kinase activity in
BMP signalling, TAK1-deﬁcient chondrocytes were reconsti-
tuted with exogenous TAK1 using a lentiviral system
(Figure 7). Tak1
col2 chondrocytes were infected with either
wt or CI TAK1 lentiviruses and selected in puromycin-con-
taining medium. As expected, TAK1 (WT)-expressing cells
exhibited an increase in Smad1/5/8 and p38 MAP kinase
phosphorylation in response to BMP2/7. In contrast, exogen-
ous expression of catalytically inactive TAK1 (CI) failed to
restore Smad1/5/8 phosphorylation (Figure 7A).
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Figure 6 Identiﬁcation of Smad1 phosphorylation sites by TAK1. (A) Phosphopeptide analysis of Smad1. HEK293 cells were transfected with
Flag-Smad1 together with either vector or HA-TAK1 (DN). After immunoprecipitation with anti-Flag conjugated agarose, Smad1 proteins were
eluted by Flag peptide, separated by SDS–PAGE, and stained with Coomassie blue (upper panel). The predicted proteolytic digestion pattern of
Smad1 (lower panel). (B) Smad1 phosphorylation by TAK1. HEK293 cells were transfected with Flag-Smad1 together with either vector, HA-
TAK1 (DN), or HA-BMPR1B (Q203D). Cells were lysed and immunoblotted with the indicated antibodies. (C) TAK1-mediated phosphorylation
of Smad1 at the C-terminal serines. HEK293 cells were transfected with either vector or HA-TAK1 (DN), and the immunoprecipitates were
mixed with wt GST-Smad1 (WT) or mutant GST-Smad1 (AAVA). TAK1 kinase activity was analysed by in vitro kinase assay. (D) BMPR1B-
mediated phosphorylation of Smad1 at the C-terminal serines. HEK293 cells were transfected with either vector or HA-BMPR1B (Q203D) and
the immunoprecipitates were mixed with wt GST-Smad1 (WT) or mutant GST-Smad1 (AAVA). BMPR1B kinase activity was analysed by in vitro
kinase assay. (E) Immortalized chondrocytes were serum starved for 12h before BMP2/7 (100ng/ml) stimulation for 20min. The TAK1
immunoprecipitates were washed under stringent conditions to minimize contamination by other endogenous proteins, mixed with
GST-Smad1 (WTor AAVA), and TAK1 kinase activity was analysed by in vitro kinase assay.
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col2 chondro-
cytes could also be reconstituted by TAK1 expression.
Exogenous expression of TAK1 (WT) signiﬁcantly increased
ID1 expression after BMP2/7 stimulation of Tak1
col2 chon-
drocytes (Miyazono and Miyazawa, 2002), whereas little
induction of ID1 was detected in vector or TAK1 (CI)-expres-
sing cells (Figure 7B). Therefore, TAK1 activates both the
canonical Smad and the p38 MAP kinase pathways through
its kinase activity, and this activity is important for the
transcriptional response to BMP2/7.
Discussion
TAK1, a MAP3K kinase family member, was originally iden-
tiﬁed as a key mediator of the p38 MAPK kinase pathway that
was activated downstream of both TGFb and BMP4
(Yamaguchi et al, 1995). However, with the exception of a
study in Xenopus demonstrating that TAK1 mediates ventral
mesoderm induction and patterning downstream of BMPs,
the in vivo role of TAK1 in BMP signalling remained unex-
plored (Shibuya et al, 1998). The involvement of BMPs in
growth, patterning, and maintenance of cartilage made this
organ system an attractive in vivo model to explore.
Early embryonic lethality in germline TAK1-deﬁcient mice
precluded genetic studies of mammalian TAK1 in skeletal
biology (Shim et al, 2005; Jadrich et al, 2006). We took
advantage of an earlier generated strain of mice with a
conditional deletion of Tak1 to generate mice lacking Tak1
selectively in chondrocytes (Xie et al, 2006). TAK1 deﬁciency
in chondrocytes caused a severe chondrodysplasia with runt-
ing, elbow dislocation, cartilage overgrowth, and tarsal
fusion, abnormalities that are variously present in mice lacking
BMPR1B, GDF5, or multiple BMP ligands (Storm et al, 1994; Yi
et al, 2000; Bandyopadhyay et al, 2006). The observation that
the Tak1 phenotype represents a mixture of BMP-associated
phenotypes indicates that TAK1 serves an essential function
downstream of multiple BMP family members. Signal transduc-
tion downstream of BMPs can be considered as a dichotomy
between the activation of MAP kinase pathways and the
canonical Smads (Derynck and Zhang, 2003; Yoon and Lyons,
2004). Earlier, TAK1 was largely considered as a proximal
activator of the MAP kinase arm of signalling, without a clear
role in Smad activation (Yamaguchi et al,1 9 9 5 ) .H o w e v e r ,t h e
reduction in both Smad and p38/Jnk/Erk MAP kinase responses
in Tak1
col2 chondrocytes indicates that TAK1 has an important
but distinct function in both signalling arms downstream of
BMP2/7.
Table I Proteolytic digestion of human Smad1 by Trypsin
Size Vector HA-TAK1 (DN)
1–15 MNVTSLFSFTSPAVK MNVTSLFSFTSPAVK
16/17–21 R/LLGWK R/LLGWK
22–28 QGDEEEK QGDEEEK
29–32 WAEK WAEK
33–39 AVDALVK AVDALVK
40/41–42 K/LK K/LK
43/44/45 K/K/K K/K/K
46–53 GAMEELEK GAMEELEK
54–69 ALSCPGQPSNCVTIPR ALSCPGQPSNCVTIPR
70–74 SLDGR SLDGR
75–80 LQVSHR LQVSHR
81/82–90 K/GLPHVIYCR K/GLPHVIYCR
91–93 VWR VWR
94–116 WPDLQSHHELKPLECCEFPFGSK WPDLQSHHELKPLECCEFPFGSK
117–118 QK QK
119–128 EVCINPYHYK EVCINPYHYK
129/130–142 R/VESPVLPPVLVPR R/VES*PVLPPVLVPR
R/VES*PVLPPVLVPR
143–157 HSEYNPQHSLLAQFR HSEYNPQHSLLAQFR
158–257 NLGQNEPHMPLNATFPDSFQQPNSHPFPHSPNSSY-
PNSPGSSSSTYPHSPTSSDPGSPFQMPADTPPPAYLP-
PEDPMTQDGSQPMDTNMMAPPLPSEINR
NLGQNEPHMPLNATFPDSFQQPNSHPFPHSPNSSY-
PNSPGSSSSTYPHSPTSSDPGSPFQMPADTPPPAYLP-
PEDPMTQDGSQPMDTNMMAPPLPSEINR
258–269 GDVQAVAYEEPK GDVQAVAYEEPK
270–282 HWCSIVYYELNNR HWCSIVYYELNNR
283–306 VGEAFHASSTSVLVDGFTDPSNN VGEAFHASSTSVLVDGFTDPSNN
/307–308 K/NR K/NR
309–319 FCLGLLSNVNR FCLGLLSNVNR
320–327 NSTIENTR NSTIENTR
328/329–332 R/HIGK R/HIGK
333–358 GVHLYYVGGEVYAECLSDSSIFVQSR GVHLYYVGGEVYAECLSDSSIFVQSR
359–373 NCNYHHGFHPTTVCK NCNYHHGFHPTTVCK
374–381 IPSGCSLK IPSGCSLK
382–408 IFNNQEFAQLLAQSVNHGFETVYELTK IFNNQEFAQLLAQSVNHGFETVYELTK
409–413 MCTIR MCTIR
414–418 MSFVK MSFVK
419–426 GWGAEYHR GWGAEYHR
427–449 QDVTSTPCWIEIHLHGPLQWLDK QDVTSTPCWIEIHLHGPLQWLDK
450–465 VLTQMGSPHNPISSVS VLTQMGSPHNPISS*VS
VLTQMGSPHNPISS*VS VLTQMGSPHNPISS*VS*
*Phosphorylation.
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col2 phenotype to the phenotype
of mice deﬁcient for BMP signalling
The Tak1
col2 phenotype is not identical to that of any single
member of the BMP signalling pathway. The degree of
runting and the delay in secondary ossiﬁcation centre forma-
tion in Tak1
col2 mice resemble that seen in mice with a
conditional deletion of Smad4 in chondrocytes (Zhang et al,
2005). Additionally, the magnitude of IHH downregulation in
Tak1
col2 hypertrophic chondrocytes is similar to that ob-
served in both Smad4 and BMPR1A conditional knockout
mice (Yoon et al, 2006). Hence, these aspects of the Tak1
col2
phenotype may be due to dysregulation of Smad signalling
downstream of BMPs. However, mice with a conditional
deletion of Smad4 in chondrocytes do not display elbow
dislocation or fusion of the tarsal bones. These features are
reminiscent of the defects seen in BMPR1B and GDF5 knock-
out mice (Storm et al, 1994; Yi et al, 2000), suggesting that
the GDF5 to BMPR1B signalling module that maintains the
integrity of the elbow joint also uses TAK1 as a necessary
signalling intermediate. The penetrance of the elbow disloca-
tion phenotype in TAK1-deﬁcient mice is higher (B80% by 2
weeks of age) than that observed in BMPR1B-deﬁcient mice
(23%). Combined with the earlier onset of the dislocation
phenotype in TAK1-deﬁcient mice, this ﬁnding suggests that
BMPR1B may have partial functional redundancy with
another receptor subunit acting upstream of TAK1. This
receptor subunit is highly likely to be BMPR1A, but the
severe cartilage defects in mice lacking both BMPR1A/B in
cartilage make analysis of this redundancy difﬁcult in vivo
(Yoon et al, 2005).
This similarity between GDF5 and Tak1
col2 phenotypes is
further supported by the ﬁnding of tarsal bone fusion (Storm
et al, 1994). However, mice with a spontaneous loss-of-
function mutation in GDF5 show only a slight shortening of
the long bones, implicating other BMP family members
upstream of TAK1. Additionally, although GDF5 mutant
mice do have fusion of the tarsal bones, they do not display
the marked medial deviation of the hindlimb phalanges seen
in Tak1
col2 mice, indicating that this deviation is not simply
secondary to ankle bone malformation. As these aspects of
the phenotype (elbow dislocation, tarsal fusion) are present
in GDF5 and BMPR1B but not Smad4-deﬁcent mice, they may
be MAP kinase dependent. However, the role of the MAP
kinase pathway in postnatal cartilage growth and develop-
ment has not been explored as thoroughly in vivo as the
role of the Smad pathway, making it difﬁcult to examine
the contribution of MAP kinase signalling to the Tak1
col2
phenotype.
TAK1 mediates phosphorylation of Smad proteins
downstream of BMPs but not TGFb
The TAK1 phenotype is notable for the absence of speciﬁc
features of mice genetically unable to respond to TGFb in
chondrocytes. In particular, mice with a deletion of TGFbR2
in chondrocytes display abnormalities in the axial skeleton,
including bifurcation of the xiphoid process, abnormal mor-
phogenesis of the C1, C2 vertebrae, and malformation of the
vertebral transverse processes, which are not present in
Tak1
col2 mice (Serra et al, 1997; Bafﬁ et al, 2004). In our
study, analysis of primary and transformed chondrocytes
revealed that TAK1 is able to phosphorylate Smad proteins
in response to BMP2/7 but not TGFb. However, Smad1
(a BMP-responsive Smad) and Smad2 (a TGFb-responsive
Smad) can both be phosphorylated by overexpressed, con-
stitutively active TAK1, indicating that TAK1 has an equiva-
lent intrinsic ability to phosphorylate both substrates.
Additionally, phosphorylation of MKK6 by TAK1 is similar
after BMP2/7 and TGFb stimulation, indicating that the
Table II Proteolytic digestion of human Smad1 by Lys-C
Size Vector HA-TAK1 (DN)
1–15 MNVTSLFSFTSPAVK MNVTSLFSFTSPAVK
16–21 RLLGWK RLLGWK
22–28 QGDEEEK QGDEEEK
29–32 WAEK WAEK
33–39 AVDALVK AVDALVK
40/41–42 K/LK K/LK
43/44/45 K/K/K K/K/K
46–53 GAMEELEK GAMEELEK
54–81 ALSCPGQPSNCVTIPRSLDGRLQVSHRK ALSCPGQPSNCVTIPRSLDGRLQVSHRK
82–116 GLPHVIYCRVWRWPDLQSHHELKPLECCEFPFGSK GLPHVIYCRVWRWPDLQSHHELKPLECCEFPFGSK
117–118 QK QK
119–128 EVCINPYHYK EVCINPYHYK
129–269 RVESPVLPPVLVPRHSEYNPQHSLLAQFRNLGQNEPHM-
PLNATFPDSFQQPNSHPFPHSPNSSYPNSPGSSSSTYPH-
SPTSSDPGSPFQMPADTPPPAYLPPEDPMTQDGSQPMD-
TNMMAPPLPSEINRGDVQAVAYEEPK
RVESPVLPPVLVPRHSEYNPQHSLLAQFRNLGQNEPHM-
PLNATFPDSFQQPNSHPFPHSPNSSYPNSPGSSSSTYPH-
SPTSSDPGSPFQMPADTPPPAYLPPEDPMTQDGSQPMD-
TNMMAPPLPSEINRGDVQAVAYEEPK
270–306 HWCSIVYYELNNRVGEAFHASSTSVLVDGFTDPSNNK HWCSIVYYELNNRVGEAFHASSTSVLVDGFTDPSNNK
307–332 NRFCLGLLSNVNRNSTIENTRRHIGK NRFCLGLLSNVNRNSTIENTRRHIGK
333–373 GVHLYYVGGEVYAECLSDSSIFVQSRNCNYHHGFHPTT-
VCK
GVHLYYVGGEVYAECLSDSSIFVQSRNCNYHHGFHPTT-
VCK
374–381 IPSGCSLK IPSGCSLK
382–408 IFNNQEFAQLLAQSVNHGFETVYELTK IFNNQEFAQLLAQSVNHGFETVYELTK
409–418 MCTIRMSFVK MCTIRMSFVK
419–449 GWGAEYHRQDVTSTPCWIEIHLHGPLQWLDK GWGAEYHRQDVTSTPCWIEIHLHGPLQWLDK
450–465 VLTQMGSPHNPISSVS
VLTQMGSPHNPISS*VS VLTQMGSPHNPISS*VS
VLTQMGSPHNPISS*VS*
*Phosphorylation.
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ligand (Yamaguchi et al, 1995). Recently, it has been reported
that the activated TGFb receptor 1 recruits TRAF6 to the
receptor complex and subsequently induces ubiquitination of
TRAF6 and promotes TRAF6 interaction with TAK1, thereby
resulting in activation of p38/JNK MAP kinases (Sorrentino
et al, 2008; Yamashita et al, 2008). However, the mechanism
of TAK1-mediated p38 MAP kinase activation downstream of
BMP signalling has not been explored. Given these observa-
tions, the most likely explanation for the selective involve-
ment of TAK1 in Smad phosphorylation downstream of BMP
but not TGFb stimulation is that another component of the
TGFb receptor complex acts to block TAK1 access to Smad2.
For such a mechanism to be effective, the active fraction of
TAK1 must be sequestered at the TGFb receptor complex.
Likewise, either the BMP receptor complex is permissive for
TAK1 and Smad1/5/8 interactions or TAK1 is released from
the receptor complex to phosphorylate Smad1/5/8 in the
cytosol.
TAK1-inducible phosphorylation of Smad1 at multiple
sites
The ﬁnding that phosphorylation levels of Smad1/5/8 at
C-terminal serines were reduced both in vivo and in vitro in
response to BMP stimulation suggested an unexpected role
for TAK1 in regulating the activity of BMP-responsive Smads.
As the immunoprecipitated TAK1 protein was able to phos-
phorylate Smad1 protein in in vitro kinase assays, we under-
took a systematic analysis of Smad1 phosphorylation using a
mass spectrometry approach (Figure 6A; Tables I and II). This
analysis showed that phosphorylation of Smad1 at the C-
terminal serines S463/S465 was increased by co-expression
of constitutively active TAK1. Mutation of this site conﬁrmed
this ﬁnding, showing an approximately 40% reduction in
TAK1-mediated phosphorylation. Additionally, our in vivo
and in vitro data show that S463/S465 phosphorylation was
moderately decreased in both hypertrophic chondrocytes and
the Tak1
col2 chondrocyte line after BMP2/7 stimulation
(Figures 3A, B and 4D). As S463/S465 phosphorylation is
critical for Smad1 activity (Kretzschmar et al, 1997b), a
reduction in S463/S465 phosphorylation would explain the
reduction in BMP signalling observed both in vivo and in vitro
in TAK1-deﬁcient chondrocytes. This implies that TAK1 may
have a function in ampliﬁcation of the signal from the BMP
receptor by increasing phosphorylation at the same S463/
S465 site targeted by the BMPR1 kinase activity.
The partial reduction in Smad1 phosphorylation observed
in S463/S465 mutated Smad1 (AAVA Smad1) indicates that
additional sites are phosphorylated by TAK1 (Figure 6C and
E). Further, the absence of detectable phosphorylation sites in
the MH1 and MH2 domain by the phosphopeptide analysis
suggests that these additional sites might lie inside the linker
region. Unfortunately, the lack of Trypsin and Lys-C cleavable
sites precluded ﬁnding phosphorylation site in this region. It
has been reported that the Smad1 linker region contains four
MAPK phosphorylation sites and two Gsk3b sites and MAPK
and Gsk3b phosphorylation of the linker region restricts
Smad1 activity by recruiting the ubiquitin ligase Smurf1,
leading to degradation of Smad1 (Kretzschmar et al, 1997a;
Fuentealba et al, 2007; Sapkota et al, 2007). As phosphoryla-
tion of these sites is important for the regulation of FGF/BMP
pathway crosstalk, it will be interesting to test the possibility
that TAK1 is involved in the regulation of BMP signalling by
FGF through its phosphorylation of those linker phosphor-
ylation sites. However, the critical role of TAK1 in BMP
signalling precludes an analysis of this crosstalk until a
component of the MAPK cascade downstream of TAK1-
mediated BMP signalling is identiﬁed.
A model of BMP receptor complex assembly
Analysis of the associations among TAK1, BMPR1A, and the
adaptor proteins XIAP and TAB1 suggests a mechanism for
TAK1 recruitment to the BMP receptor complex. In BMP
signalling pathways, X-linked inhibitor of apoptosis protein
(XIAP) functions as an adapter protein that connects the
BMPR complex with the TAB1–TAK1 complex through its
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Figure 7 TAK1 kinase activity is important for BMP signalling.
(A, B) Immortalized chondrocytes were infected either by vector
control, TAK1 (WT), or TAK1 (CI) lentivirues and selected in
puromycin-containing medium. (A) Cells were serum starved for
12h before BMP2/7 (100ng/ml) stimulation for the indicated time
and immunoblotted with antibodies speciﬁc to phospho-Smad1/5/8
and phospho-p38. Immunoblotting with anti-Hsp90 and -TAK1
antibodies were performed for protein loading control and TAK1
expression, respectively. (B) Alternatively, cells were unstimulated
or stimulated with BMP2/7 for 6h and total RNA was extracted for
RT–PCR analysis. (C) Schematic model of TAK1 function in BMP
signalling pathways.
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Yamaguchi et al, 1999). Our in vitro experiments demonstrate
that BMPR1A binds to XIAP, XIAP in turn mediates the
interaction between BMPR1A and TAB1, and TAB1 mediates
the interaction between XIAP and TAK1 (Supplementary
Figure S5A–C). As the interaction of BMPR1A with XIAP
occurs normally in TAK1-deﬁcient chondrocytes, TAK1
functions downstream of the BMPR–XIAP complex
(Supplementary Figure S5D).
Hence, we propose a model wherein BMPR1A is connected
to the TAK1 complex (TAK1–TAB1) through XIAP, and TAK1
mediates canonical Smad and p38 MAP kinase activation
downstream of BMP signalling (Figure 7C). On BMP stimula-
tion, the activated BMPRI recruits Smad 1/5/8 directly, and
the TAK1 complex (TAK1–TAB1) is recruited to the receptor
by the adaptor XIAP. R-Smads can be phosphoryated by the
type I BMPR and TAK1 at either S463/465 (Smad1/5) or
S426/428 (Smad8). Activated R-Smads, in turn, bind to
Smad4, translocate into the nucleus, and mediate BMP-re-
sponsive gene expression (i.e. IHH, ID1, Noggin, and Msx1).
Alternatively, the TAK1 complex can activate the MKK3/6-
p38 MAP kinase pathway.
Our results do not exclude the possibility that TAK1 may
participate in the regulation of other BMP signalling inter-
mediates and other signalling pathways. Indeed, in TAK1-
deﬁcient chondrocytes, a decreased phosphorylation of p38
MAP kinase was detected in response to TGFb, and phos-
phorylation of JNK and ERK MAP kinases and IkBa was also
decreased after BMP stimulation (Figure 4D and F and data
not shown).
Materials and methods
Cells, plasmids, and antibodies
HEK 293 cells (human kidney embryonic cells) were purchased
from ATCC and cultured in DMEM medium (Cellgro) containing
10% FBS, 2mM L-glutamine and 1% penicillin/streptomycin.
Primary and immortalized chondrocytes were cultured in DMEM-
F12 medium (Cellgro) containing 2% FBS, 2mM L-glutamine, 1%
penicillin/streptomycin, 1% non-essential amino acids, Na-Selenate
and transferrin. Plasmids for HA-ALK3, Myc-XIAP and HA-TAK1
(WT, DN, and DN/K63W), SV40 large T Ag, Myc-tagged TAK1
mutants, and GST-Smad1, 2, 3, and 4 were the gifts of Drs Hiroshi
Shibuya, Kunihiro Matsumoto, Jun Ninomiya-Tsuji, Nobuyuki
Tanaka, Xia-fan Wang, Ki-young Lee, and Zhijie Chang, respec-
tively. Plasmid for LPCX-BMPR1B (Q203D) was purchased from
Addgene. GST-Smad1 (AAVA) and TAK1 (WT and DN/K63W)
cDNAs were PCR ampliﬁed and cloned into pGEX vector
(Amersham Pharmacia) and pHASE/PGK-PURO lentiviral vector,
respectively. Antibodies used were anti-TAK1 (Millipore); anti-HA,
anti-c-Myc, and anti-BMPR-1A (Santa Cruz); anti-Smad2, anti-
phospho-Smad1/5/8, anti-phospho-Smad2 (S465/467), and anti-
phospho-p38 (Cell Signaling); anti-Smad1 (Invitrogen); anti-Flag
(M2, Sigma); anti-Smad4 (Abcam); anti-XIAP (Stressgen); and anti-
GAPDH (Afﬁnity Bioreagents). Cells were treated with rhBMP2/7
and mTGFb (R&D Systems) as indicated. To minimize interference
of XIAP detection by the heavy and light chains of the
immunoprecipitating BMPR1A antibody, mouse Trueblot ULTRA
kit (eBioscience) was used for interaction analysis of BMPR1A with
XIAP (Supplementary Figure S5E).
Generation of cartilage-speciﬁc TAK1-deﬁcient mice
Tak1
ﬂ/ﬂ mice were intercrossed with the earlier described Col2-cre
deleter strain to generate Tak1
ﬂ/ﬂ.Col2-cre mice (Ovchinnikov et al,
2000). As Tak1
ﬂ/ﬂ.Col2-cre mice do not survive beyond 3 weeks of
age, the line was maintained as an intercross of Tak1
ﬂ/þ.Col2-cre
and Tak1
ﬂ/ﬂ mice. Animals were maintained in accordance with the
NIH Guide for the Care and Use of Laboratory Animals and were
handled according to protocols approved by the institution’s
subcommittee on animal care (IACUC).
Generation of mouse chondrocytes
Chondroepiphyses were dissected from the long bones of day 1
newborn pups from the intercross of Tak1
ﬂ/þ.Col2-cre and Tak1
ﬂ/ﬂ
mice. They were washed with PBS and incubated with 2mg/ml
collagenase P (Roche) for 2–4h at 371C. The cell suspension was
plated in six-well plates containing DMEM-F12 supplemented with
2% FBS (Gosset et al, 2008). Tak1
ﬂ/ﬂ.Col2-cre chondrocytes were
identiﬁed by immunoblotting with TAK1 antibody and PCR
genotyping using tail DNA. To immortalize primary chondrocytes,
cells were stably transfected with linearized SV40 Large T antigen
plasmid (Kobayashi et al, 2005; Shim et al, 2005) using Effectene
trasnfection reagent (Qiagen).
Skeletal preparation and histology
The mineralization pattern of the skeleton was analysed at 20 days
after birth using the method of McLeod (McLeod, 1980). Brieﬂy,
mice were killed by CO2 narcosis, skinned, eviscerated, and ﬁxed in
95% ethanol. Then skeletons were stained by Alizarin red S/Alcian
blue and sequentially cleared in 1% potassium hydroxide. For
histological analyses, parafﬁn sections of bones were produced
from E18.5, p0, and p20 mice. Limb tissues were dissected and ﬁxed
in 4% paraformaldehyde (PFA) in PBS. They were then decalciﬁed
by daily changes of 15% tetrasodium EDTA until soft and pliable.
Tissues were dehydrated by passage through an ethanol series,
cleared twice in xylene, embedded in parafﬁn, and sectioned. For
morphological analyses, tissue sections were stained with haema-
toxylin and eosin.
In situ hybridization
For in situ hybridization, probe plasmids of Collagen X, IHH, and
ID1 were kindly provided by Drs Bjorn Olsen, Beate Lanske, and
Kuni Tsuji, respectively. DIG labelled probes were prepared using
the DIG labelling kit (Roche) as per the manufacturer’s instructions.
Brieﬂy, probes were puriﬁed by washing over a Ultrafree-MC ﬁlter
column (Millipore). Tissue sections were prewarmed at 551C and
deparafﬁnized and rehydrated by passage through xylene and 100,
95, and 70% ethanol. Endogenous peroxidase activity was
quenched by 15min incubation in 3% hydrogen peroxide. Samples
were treated with 10mg/ml proteinase K for 15min, 4% PFA for
5min, and 0.25% acetic acid for 15min before being dehydrated by
passage through increasing concentrations of ethanol. Probe
was added to the hybridization solution (50% formamide, 10mM
Tris–HCl pH 7.5, 200mg/ml tRNA, 1  Denhardt’s, 10% Dextran
sulphate, 600mM NaCl, 0.25% SDS, 1mM EDTA) and the solution
prewarmed to 851C before incubation with the tissue sections
overnight. After incubation, sections were washed with standard
sodium citrate buffer and treated with 10mg/ml RNaseA in TNE
buffer (10mM Tris–HCl, 100mM NaCl, 1mM EDTA). DIG-labelled
probe was then detected by immunostaining with anti-DIG-POD
and streptadvidin-horseradish peroxidase.
Immunohistochemistry
For IHC, parafﬁn tissue sections were de-waxed and endogenous
peroxidase quenched as in preparation for in situ hybridization. For
anti-TAK1 staining, sections were then incubated with hyaluroni-
dase. For anti-phospho-Smad1/5/8 staining, sections were heated in
a pressure cooker. Sections were blocked with 3% goat serum, 1%
BSA, 0.1% Triton X 100 in PBS for 1h at room temperature and
incubated with antibodies speciﬁc for TAK1 or phospho-Smad1/5/8
at 41C overnight. Sections were then treated with TSA-biotin (Perkin
Elmer) and streptavidin-HRP as per manufacturer’s instructions,
and HRP visualized with DAB (2,20-diaminobenzidine tetra-
hydrochloride).
Phosphopeptide analysis
HEK293 cells grown on three 10cm petri dishes were transiently
transfected using Effectene transfection reagent (Qiagen) with Flag-
Smad1 together with either vector or HA-TAK1 (DN). Flag-Smad1
protein was immunoprecipitated with anti-Flag conjugated agarose
overnight at 41C, eluted by Flag peptide, separated by SDS–PAGE,
and stained with coomassie blue. Gel band containing Flag-Smad1
was excised and subjected to in-gel reduction and alkalyation
followed by Lys-C or trypsin digestion. Digested peptides
were extracted from the gel and analysed by liquid chromatography
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gradient ranging from 4 to 27% (v/v) acetonitrile in 0.1% (v/v)
formic acid in a microcapillary (125mm 18cm) column packed
with C18 reverse-phase material (Magic C18AQ, 5mm particles,
200A ˚ pore size, Michrom Bioresources) and on-line analysed on
The LTQ Orbitrap XL
TM hybrid FTMS (Thermo Fisher Scientiﬁc). For
each cycle, one full MS scan acquired on the Orbitrap at high mass
resolution was followed by 10 MS/MS spectra on the linear ion trap
XL from the 10 most abundant ions. MS/MS spectra were searched
using the Sequest algorithm against Smad1 protein with dynamic
modiﬁcation of methionine oxidation and serine, threonine and
tyrosine phosphorylation. All peptide matches were ﬁltered based
on mass deviation, tryptic state, XCorr, and dCn and conﬁrmed by
manual validation.
Luciferase reporter assay
Immortalized chondrocytes grown on 12-well plates were transi-
ently transfected using Effectene transfection reagent (Qiagen) with
the BMP (Tlx2-lux) or TGFb-dependent reporter construct (3TP-luc)
together with the Renilla luciferase vector (Promega). Total DNA
concentration in each experiment was maintained by adding the
appropriate control vector to the DNA mixture. At 24h after
transfection, cells were serum starved for 12h before treatment
with BMP2/7 or TGFb. After 24h, cells were lysed and luciferase
activity was measured using the dual luciferase assay kit
(Promega).
In vitro kinase assay
For in vitro kinase assays, immortalized chondrocytes grown on
10cm petri dishes were serum starved for 12h before treatment
with either BMP2/7 (100ng/ml) or TGFb (2ng/ml) and then lysed
in TNT lysis buffer (1% triton X-100, 50mM Tris, pH 7.5, 200mM
NaCl, protease inhibitors). Alternatively, HEK293 cells were
transiently transfected with vector, HA-tagged TAK1 (DN or CI).
Protein levels in each lysate were determined using a Bio-Rad
protein assay kit (Bio-Rad) and then normalized among the
samples. Protein from lysates was immunoprecipitated using either
anti-TAK1 antibody or Rabbit IgG and protein A-sepharose or anti-
HA conjugated agarose overnight at 41C and precipitates were
incubated for 15min at 301C in kinase buffer (20mM HEPES, pH
7.5, 20mM MgCl2, 1mM EDTA, 2mM NaF, 2mM-glycerophosphate,
1mM DTT, 10mM ATP) containing appropriate GST-fused Smad
proteins and 10mCi of [g32P]ATP (PerkinElmer). The substrates
were then precipitated using glutathione-agarose (Novagen),
resolved by SDS–PAGE and phosphorylated proteins were visua-
lized by autoradiography.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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